ClinicalTrials.gg
RecruitingNCT07721701digiDEM BayernUpdated Jul 23, 2026

Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers

An observational study in Mild Cognitive Disorder, Alzheimer Disease and Vascular Dementia, sponsored by University of Erlangen-Nürnberg Medical School. Recruiting at 12 sites in Germany. Per ClinicalTrials.gov, last updated 2026-07-23.

Primary conditionDementiaRegistry: Neurocognitive DisordersReclassifiedWhy we changed it
Registry
Neurocognitive Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Dementia
Why
  1. The study's listed conditions name Dementia, a narrower term within Neurocognitive Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Erlangen-Nürnberg Medical School · Observational

From the registry’s dates

  • Started Aug 2020; still recruiting 6 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 96 studies in Dementia with a site in Germany — 13 open to participants now, 18 under way, 8 of them phase 3. Dementia · Germany.

Planned enrollment
2nd of 18
5,000 · median 441
Started
2020
with 3 others
Observational
18 of 96
5 open now
Primary completion
2031-12
later than 14 of 17 live
Registered
96th of 96
by date

Among the 96 studies in Dementia with a site in Germany, this one is the 2nd largest by planned enrollment of the 18 observational ones that give a count, is one of 4 that started in 2020, is one of 18 observational ones, reaches primary completion later than 14 of the 17 other live ones, and was the 96th registered.

Dementia

2,372 studies on the registry are indexed under Dementia; 574 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 256 across 553 observational studies indexed under Dementia.

Browse Dementia studies →

Open to participants now

13 of the 96 studies in Dementia with a site in Germany are open now.

All 13 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 381 Dementia studies recruiting now, 242 (64%) set no upper age limit and 25 (7%) stop at 75 or younger; 16 take children under 18; 163 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Dementia with a site in Germany, or all of them as a file.
02

Study summary

Around 57 million people worldwide live with dementia, with approximately 10 million new cases diagnosed each year. By the end of 2023, around 1.8 million people were living with dementia in Germany, the majority of whom were over 65 years of age (1.7 million). In Bavaria, around 257,000 people were living with dementia in 2023. Providing care and support for these people in the future is one of the biggest challenges not only for the healthcare system, but also for society as a whole. This is particularly true when it comes to caring for people with dementia in rural areas.

The Digital Dementia Registry Bavaria (digiDEM Bayern) is a health outcomes research project that aims to improve understanding of the clinical complexity, long-term progression, and care situation of dementia.

digiDEM Bayern is a multicenter longitudinal study conducted in all administrative districts of Bavaria. Participants from both urban and rural areas are included. Participants are people with mild cognitive impairment (MCI) and people with mild to moderate dementia (defined according to ICD-10: F06.7, F00-F03) who are cared for at home by their family caregivers, as well as the family caregivers themselves.

Prior to study enrollment, participants with cognitive impairments are assessed for their suitability for the study using brief cognitive tests (Mini Mental State Examination, Montreal Cognitive Assessment). Participants are then interviewed at several points in time (baseline, after 6 months, after 12 months, annually) on the basis of standardized, face-to-face interviews. Participation is voluntary. As part of the informed consent process, participants will be informed about the project in advance and asked to consent to participate in the study.

Participants are recruited in all administrative districts in Bavaria. Participants are recruited and surveyed through institutions that are active in counseling, care, diagnosis, treatment, and care for people with dementia, including counseling facilities, care groups, and residential communities, as well as outpatient (memory clinics, outpatient care services, general practitioners and specialists), inpatient (acute care hospitals, district clinics, geriatric rehabilitation facilities) and semi-inpatient (geriatric day clinics, day care facilities) institutions.

03

Conditions studied

  • Mild Cognitive Disorder
  • Alzheimer Disease
  • Vascular Dementia
  • Dementia in Other Diseases Classified Elsewhere
  • Unspecified Dementia

Browse trials for

Keywords

  • MCI
  • Dementia
  • Registry
  • Digital
  • Alzheimers Disease
04

In context

Dementia Reclassified

2,372 studies on the registry are indexed under Dementia; 574 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 256 across 553 observational studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

University of Erlangen-Nürnberg Medical School is the lead sponsor of 276 studies on the registry; 52 are open to participants now.

Compared within Dementia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Neurocognitive Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants are recruited and surveyed through institutions that are active in counseling, care, diagnosis, treatment, and care for people with dementia, including counseling facilities, care groups, and residential communities, as well as outpatient (memory clinics, outpatient care services, general practitioners and specialists), inpatient (acute care hospitals, district clinics, geriatric rehabilitation facilities) and semi-inpatient (geriatric day clinics, day care facilities) institutions

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People with an score of 24-30 points and an additional MoCA score of 0-23 points
  • People with an MMSE score of 15-23 points
  • Living in a home environment
  • All types of MCI and dementia according to the ICD-10 classification (F06.7, F00-F03)
  • Main residence in Bavaria
  • All age groups

Exclusion criteria

Exclusion Criteria:

  • People with an MMST score of 24-30 points and an additional score of 24-30 points
  • People with an MMST score of 0-14 points
  • Permanent residence in a nursing home
  • Psychiatric diagnoses (among others depression, schizophrenia, addiction)
  • Deafness and/or blindness
  • Aphasia
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • People with cognitive impairments

    People with mild cognitive impairment and people with dementia

  • Family caregivers

    Family caregivers of the people with cognitive impairments

07

What researchers measure

Primary outcomes

  1. Postal code

    Time frame: Baseline

  2. Age

    in years

    Time frame: Baseline

  3. Gender

    Time frame: Baseline

  4. Country of birth

    Time frame: Baseline

  5. Parents' country of birth

    Time frame: Baseline

  6. Most often spoken language in the household

    Time frame: Baseline

  7. Religion

    Time frame: Baseline

  8. Education

    Time frame: Baseline

  9. Vocational training

    Time frame: Baseline

  10. Employment status

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  11. Marital status

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  12. Number of children

    in general and those, who live in the same household

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  13. Number of persons living in the household

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  14. Relationship between the person with cognitive impairment and the family caregiver

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  15. Living arrangements

    Which kind of living arrangement (own home environment, assisted living, shared apartment, others) and who are the people, who live in this arrangement (family caregiver, spouse, children, siblings, others)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  16. Powers of attorney and guardianship

    Existence of a power of attorney for health care, a living will, and legal guardianship (Vorsorgevollmacht, Patientenverfügung, gesetzliche Betreuung)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  17. Severe disability

    Does a person with cognitive impairments have a severe disability? (according to German law)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  18. Name of the health insurance company

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  19. Monthly net income

    in Euro and in categories (e.g. 0-1000€)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  20. Use of care leave

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  21. Time of onset of the first symptoms

    as date

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  22. Dementia diagnosis

    according to ICD-10

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  23. Time of diagnosis

    as date

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  24. Age at the time of diagnosis

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  25. Person, who initiated the diagnostic evaluation

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  26. Facility, where the diagnosis was made

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  27. Specialist who made the diagnosis

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  28. Charlson Comorbidity Index (CCI)

    Total Score Range: 0-32 (without dementia), higher values indicate a worse (greater) comorbid disease burden, data collected only at memory-clinics

    Time frame: Baseline

  29. Risk factors

    data collected only at memory-clinics

    Time frame: Baseline

  30. Measures that were used for diagnostic evaluation

    medical history, imaging, laboratory diagnostics, specific measures, data collected only at memory-clinics

    Time frame: Baseline

  31. Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

    Higher values indicate better cognitive performance, data collected only at memory-clinics

    Time frame: Baseline

  32. Mini Mental State Examination (MMSE)

    Total Score Range: 0-30, higher values indicate better cognitive performance

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  33. Montreal Cognitive Assessment (MoCA)

    Total Score Range: 0-30, higher values indicate better cognitive performance

    Time frame: Baseline

  34. Barthel-Index

    Total Score Range: 0-100, higher values indicate better functional independence (less disability)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  35. Neuropsychiatric Inventory (NPI)

    12 domains, each frequency (1-4) × severity (1-3), Total Score Range: 0-144, higher values indicate worse (more/severe) neuropsychiatric symptoms

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  36. Number of falls requiring treatment in the last six months

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  37. Tendency to wander

    Is the person with cognitive impairment trying to run away from home?

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  38. Resource Utilization in Dementia (RUD)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  39. Dementia Assessment of Service Needs (DEMAND)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  40. EuroQoL 5D (EQ-5D)

    Total Score Range: -0.661 to 1, higher values indicate a better health-related quality of life

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  41. Lubben Social Network Scale (LSNS)

    Total Score Range: 0-60, higher values indicate a better social network/less social isolation

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  42. Sources of information on health topics

    Internet, TV/ radio, books, courses and lectures, newspaper and magazines, family, friends and collegues, pharmacies, healthcare professional, others (measured on a Likert scale, from unimportant to very important)

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  43. Last time, the internet was used

    in categories

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  44. Average internet usage over the past three months

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  45. Devices that were used to access the internet

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  46. Purposes for using the Internet

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  47. Reasons for non-use of the internet

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  48. Mobility

    Possession of a driver's licence and active participation in traffic

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  49. Burden Scale for Family Caregivers (BSFC)

    Total Score Range: 0-30, higher values indicate a worse (greater) caregiver burden

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  50. Benefits of Being a Caregiver Scale (BBCS)

    Total Score Range: 0-50, higher values indicate a better (more) perceived benefits from caregiving

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

  51. Short Form 12 Health Survey (SF-12)

    Physical health and mental health summary scores, Total Score Range: 0-100, norm based scoring, higher values indicate a better physical/mental health status

    Time frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months

08

Study locations

12 of 12 sites recruiting
09

References and documents

Publications

  • Dietzel N, Kurten L, Karrer L, Reichold M, Kohler L, Nagel A, Chmelirsch C, Seebahn K, Hladik M, Meuer S, Kirchner A, Holm K, Selau M, Wendel M, Trinkwalter J, Prokosch HU, Graessel E, Kolominsky-Rabas PL. Digital Dementia Registry Bavaria-digiDEM Bayern: study protocol for a multicentre, prospective, longitudinal register study. BMJ Open. 2021 Feb 8;11(2):e043473. doi: 10.1136/bmjopen-2020-043473. PubMed 33558357 ↗
  • Reichold M, Dietzel N, Chmelirsch C, Kolominsky-Rabas PL, Graessel E, Prokosch HU. Designing and Implementing an IT Architecture for a Digital Multicenter Dementia Registry: digiDEM Bayern. Appl Clin Inform. 2021 May;12(3):551-563. doi: 10.1055/s-0041-1731286. Epub 2021 Jun 16. PubMed 34134149 ↗

Individual participant data

Plan to share: Yes — Researchers who wish to use data from digiDEM Bayern must submit a request to the scientific project management. The scientific project management retains the final authority to decide on access to and use of data and ensures that it is used only for scientific purposes and in the public interest. An application for access may only be submitted by researchers from Germany or other countries where the European Union's General Data Protection Regulation (GDPR) applies.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2020 (actual). Primary completion is estimated for Dec 2031, 136 months after the start.

Of 271 non-industry observational studies under Dementia, half reached primary completion within 74 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 202. This study's planned 136 months is above that.

Counting every sponsor, half of 293 studies reached it within 67 months; a quarter within 29 and three quarters within 188.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Jul 23, 2026
StartActual
Aug 10, 2020
Primary completionEst.
Dec 31, 2031
CompletionEst.
Dec 31, 2031
Last update
Jul 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07721701
Collaborators
Universitätsklinikum Erlangen, Medical Valley EMN e. V.
Responsible party
Sponsor
First posted
Jul 23, 2026
Start date
Aug 10, 2020
Primary completion
Dec 31, 2031 (estimated)
Completion
Dec 31, 2031 (estimated)
Last update
Jul 23, 2026

Study contacts

Peter L. Kolominsky-Rabas, Univ.-Prof. Dr. med.
Contact
peter.kolominsky-rabas@fau.de
+49 9131 85-35855

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion